Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Topic: The Abscopal Effect as a Treatment for Cancer - New Advances

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 28 Feb 2023

Guest Editor(s)

  • Prof. Steven N. Fiering
    Microbiology and Immunology at Dartmouth Geisel School of Medicine, Lebanon, NH, USA.

    Website | E-mail

Special Issue Introduction

The abscopal effect is a hypothesis that describes why sometimes using local treatment to one area of metastatic cancer (such as radiation therapy) may result in cancer shrinking in an untreated area. While this phenomenon was considered rare in the past, it has become more frequent with the advent of immunotherapy drugs such as checkpoint inhibitors to treat cancer. The underlying mechanism for this phenomenon is still unclear, but it is thought that the localized treatment might prime the immune system to attack cancer cells in a distant region. Therefore, JCMT plans to establish a special issue “The Abscopal Effect as a Treatment for Cancer - New Advances” focusing on, but not limited to, the following topics:
1. The abscopal effect in the era of checkpoint inhibitors;
2. The abscopal effect of radiation therapy and the role of DNA damage;
3. Abscopal effect of in situ vaccination and local immunotherapy;
4. Immune pathways mediating the abscopal effect, etc.

Submission Deadline

28 Feb 2023

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 28 Feb 2023
Contacts: Gladys Di, Assistant Editor,

Published Articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties